Vivos Therapeutics announces exercise of warrants for $4.64M gross proceeds
Source: SeekingAlpha
2026-01-16 08:09:06 ET
More on Vivos Therapeutics
- Vivos Therapeutics signals continued revenue acceleration amid SCN integration and SAMC expansion plans
- Seeking Alpha’s Quant Rating on Vivos Therapeutics
Read the full article on Seeking Alpha
For further details see:
Vivos Therapeutics announces exercise of warrants for $4.64M gross proceeds
Vivos Therapeutics Inc.
NASDAQ: VVOS
VVOS Trading
5.59% G/L:
$1.4254 Last:
336,710 Volume:
$1.34 Open:
VVOS Latest News
February 05, 2026 08:45:00 am
Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth's Groundbreaking FDA-Cleared Allergy and Sleep Technologies
January 20, 2026 05:31:09 pm
Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds
January 16, 2026 08:00:00 am
Vivos Therapeutics Announces Exercise of Warrants for $4.64 Million Gross Proceeds
December 16, 2025 08:45:00 am
Vivos Therapeutics Announces Grand Opening of Affiliated Sleep Center Near Detroit, Michigan
VVOS Stock Data
$16,280,184
8,040,995
N/A
7
N/A
Medical Equipment & Supplies
Healthcare
US
Littleton
